Lung Vascular Injury with Protease Infusion Relationship to Plasma Fibronectin
- 1 August 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 202 (2) , 240-247
- https://doi.org/10.1097/00000658-198508000-00016
Abstract
Fibronectin exists in a soluble form in plasma and an insoluble form in tissues. Plasma fibronectin can modulate phagocytic function as well as incorporate into the tissue matrix where it is believed to influence microvascular integrity and tissue repair. The temporal alterations in plasma and lung lymph fibronectin were studied in relation to increased pulmonary vascular permeability induced by protease infusion. The acute sheep lung lymph fistula model was used. A 39% decrease in plasma fibronectin (control = 421 .+-. 67 .mu.g/ml) was observed 2.5 h (255 .+-. 43 .mu.g/ml) after protease infusion. There was an elevation of lymph fibronectin early after protease infusion, followed by a progressive decline. Concomitant with the decrease in plasma fibronectin, an increase in lymph flow (QL) of > 200% (from a control of 6.7 .+-. 1.0 ml/h-13.9 .+-. 1.4 ml/h) was observed within 2.5 h. Also, there was a sustained elevation in the total protein lymph/plasma concentration (L/P) ratio, which was maximal at 2.5 h. The transvascular protein clearance (TVPC + QL x L/P) was 4.5 .+-. 0.7 ml/h at the control period and 13.1 .+-. 2.0 ml/h by 2.5 h. This was indicative of increased flux of protein-rich fluid across the pulmonary endothelial barrier. Lung vascular permeability stabilized after 2.5 h as manifested by a slowly declining L/P ratio. Thus, plasma fibronectin deficiency may contribute to the etiology of increased lung vascular permeability with protease infusion. Since the progressive decline in plasma fibronectin was not reflected in a proportional increase in lymph fibronectin, plasma fibronectin may have sequestered in tissues such as the lung, or perhaps in reticuloendothelial cells during the injury phase. Whether the progressive decrease in plasma fibronectin reflects its incorporation into the endothelial barrier matrix where it may mediate stabilization of the pulmonary microvascular barrier remains to be determined.This publication has 38 references indexed in Scilit:
- Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin.Journal of Biological Chemistry, 1978
- Distribution of a major connective tissue protein, fibronectin, in normal human tissues.The Journal of Experimental Medicine, 1978
- Binding of soluble form of fibroblast surface protein, fibronectin, to collagenInternational Journal of Cancer, 1977
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977
- Comparative disappearance and localization of isotopically labeled opsonic protein and soluble albumin following surgical trauma.1976
- Preparation of chronic lung lymph fistulas in sheepJournal of Surgical Research, 1975
- Increased Sheep Lung Vascular Permeability Caused by Pseudomonas BacteremiaJournal of Clinical Investigation, 1974
- Respiratory Complications in Acute PancreatitisAnnals of Surgery, 1974
- A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis.1971
- Reticuloendothelial blockade and recovery as a function of opsonic activityAmerican Journal of Physiology-Legacy Content, 1969